Content related to the development and manufacture of biopharmaceutical products and technology. (For example: genetic engineering, vaccines, proteins, molecules etc.)
Yes, penicillin allergies are real. Common symptoms include diarrhea and nausea and in rare cases, anaphylactic shock. You might have had an abnormal reaction to a dose of penicillin when you were younger. You may be wary about taking any further penicillin-based shots. But chances are, your immune system has already outgrown it, or you […]
“Don’t worry, you’ll outgrow it!” “Asthma? You’re too old for that.” If you’ve heard either of these statements from friends or family, your frustration is certainly understandable. Although it is true that some adults outgrow their asthma symptoms and fewer adults suffer from the condition versus children, the fact remains that approximately 18 million adults […]
Indian Pharma industry is currently undergoing unprecedented changes. There is huge growth in Indian Pharma because the industry has received product patents. This has been instrumental in the industry’s huge achievement as a international exporter of superlative generic drugs. The new patent regime had led to the return of the pharmaceutical multinationals. India is evolving […]
In a world swathed in layers of mobile-users, tech savvy surfers and app developers, the synthesis of an application for genetics was only a matter of time. The latest innovation to have struck the bell is Helix-an online app for chronicling all your genetic information in order to endow you with a better comprehension and […]
The strife to fight antibiotic-resistant bacterial disease has been both incessant and intrepid. But with the advent of a new tool engineered by nanotechnology and the usage of light, has facilitated certain possibilities of bringing this strife to a culmination. Apart from the worldwide endeavours to pre-empt and suppress the overuse of antibiotic drugs, the […]
Genetic engineers and researchers alike have explicitly shared their affinity towards the gene-editing tool called CRISPR–Cas9. This device alters targeted genes effortlessly, thereby permitting an executable approach to developing treatments and cures. There is, however, a major limitation to Cas9 in terms of rectifying an isolated DNA letter in a gene. To address and remedy […]
Millions of adults are diagnosed as obese each year worldwide. Many of these people suffer from a disorder known as metabolic syndrome, which includes symptoms such as hypertension and elevated blood cholesterol. They are also at risk of developing additional diseases, such as heart disease and diabetes mellitus. Obesity may, in fact, be a major […]
Although currently small and narrowly focussed on a few disease areas and countries, the Biosimilars landscape is set to expand as patents expire on leading biologics, US legislation comes into effect, vision for pharma emerging markets and payers push for their wider adoption to manage burgeoning costs. The signs are visible, but questions remain. How […]
Many of the blockbuster biological products that currently dominate the markets are coming to the end of their patent protection. The opportunity to provide more affordable “generic” versions is now attracting the interest of both generic and research-based pharmaceutical companies. The development of “generic” biological medicines referred to as “biosimilars” in Europe and increasingly in […]